Problem-solving articles |
|
Shandala M.G.
Microbiotic risks of the antimicrobial effects of disinfectant prevention of diseases
|
4-6 |
Epidemic situation |
|
Bondarenko A.L., Abbasova S.V., Korobitsyn K.G.
Hemorrhagic fever with renal syndrome in the Kirov Region at the present stage
|
7-12 |
Original investigations |
|
Feldblium I.V., Golodnova S.O., Semerikov V.V.
The level and annual dynamics of S. pneumoniae carriage among different adult population groups
|
13-16 |
|
Mardanly S.G., Avdonina A.S., Rotanov S.V., Gotvyanskaya T.P., Tomashevskaya N.A., Mukhina A.I., Khozhainova M.P.
The detection rate of antibodies to TORCH agents in the residents of certain regions of the Russian Federation
|
17-26 |
|
Borisenko G.T., Kiklevich V.T.
Early diagnosis of ENT diseases in children with respiratory infection
|
27-32 |
|
Fokina E.G., Astrina O.S., Aleshina N.I., Mitrofanova M.Yu.
Is antithrombotic therapy necessary in erysipelas?
|
33-43 |
Reviews and lectures |
|
Andreeva I.V., Stetsiouk O.U., Kozlov R.S.
Current approaches to the specific prevention of pneumococcal infection: Whom, when, what?
|
44-57 |
Exchange of experience |
|
Kravchenko A.V., Orlova-Morozova E.A., Shimonova T.E., Kozyrev O.A., Nagimova F.I., Bychko V.V., Vostokova N.V., Zozulya O.V.
The efficacy and safety of a new Russian HIV non-nucleoside reverse transcriptase inhibitor (VM-1500, Elpivirine) as a component in an antiretroviral therapy regimen
|
58-64 |
|
Saltykova T.S., Romanenko V.V., Minaeva O.V.
Epidemiological and economic efficiencies of immunization with the commercial influenza vaccine Grippol® plus in the able-bodied adult population
|
65-71 |
History of medicine |
|
Briko N.I., Sokоlova T.V., Klushkina V.V.
Epidemiological approach in F.F. Erisman’s prophylactic activity
|
72-76 |
|
Podunova L.G.
On the occasion of the 115th birth anniversary of Tikhon Efimovich Boldyrev, USSR Principal Sanitary Inspector
|
77-79 |
Русский
